*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 19.91 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 101,617 | ||||
| Total Hospitalizations with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 1,242 | ||||
| DRG Share of Total Hospitalizations | 0.31 | ||||
| % of Total ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter in DRG | 15.96 | ||||
| Avg LOS at DRG | 9.5 | ||||
| Avg LOS with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 11.6 | ||||
| Readmission Rate at DRG | 26.88 | ||||
| Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 29.2 | ||||
| Unplanned Readmission Rate at DRG | 19.26 | ||||
| Unplanned Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 25.17 | ||||
| Total Medicare payments at DRG | $1,599,186,807 | ||||
| Total Medicare payments with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $22,974,769 | ||||
| Total Medicare payment per Day at DRG | $1,656 | ||||
| Total Medicare payment per Day with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $1,594 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,737 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $18,498 | ||||
| Total Medicare Charges at DRG | $4,836,538,333 | ||||
| Total Medicare Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $69,001,990 | ||||
| Avg Charges at DRG | $47,596 | ||||
| Avg Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $55,557 | ||||
| Mortality Rate at DRG | 2.8 | ||||
| Mortality Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 20.21 | ||||
| SNF Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 10.06 | ||||
| Home Discharge Rate at DRG | 20.17 | ||||
| Home Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 13.85 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 945: REHABILITATION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 539,642 | ||||
| Total Hospitalizations with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 253 | ||||
| DRG Share of Total Hospitalizations | 1.64 | ||||
| % of Total ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter in DRG | 3.25 | ||||
| Avg LOS at DRG | 6.42 | ||||
| Avg LOS with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 14.41 | ||||
| Readmission Rate at DRG | 26.55 | ||||
| Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 34.74 | ||||
| Unplanned Readmission Rate at DRG | 20.01 | ||||
| Unplanned Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 24.88 | ||||
| Total Medicare payments at DRG | $5,267,842,463 | ||||
| Total Medicare payments with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $4,924,132 | ||||
| Total Medicare payment per Day at DRG | $1,520 | ||||
| Total Medicare payment per Day with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $1,351 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,762 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $19,463 | ||||
| Total Medicare Charges at DRG | $25,503,568,329 | ||||
| Total Medicare Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $20,808,657 | ||||
| Avg Charges at DRG | $47,260 | ||||
| Avg Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $82,248 | ||||
| Mortality Rate at DRG | 5.62 | ||||
| Mortality Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 6.72 | ||||
| SNF Discharge Rate at DRG | 19.26 | ||||
| SNF Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 23.32 | ||||
| Home Discharge Rate at DRG | 39.65 | ||||
| Home Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 23.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 055: NERVOUS SYSTEM NEOPLASMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 286,456 | ||||
| Total Hospitalizations with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 140 | ||||
| DRG Share of Total Hospitalizations | 0.87 | ||||
| % of Total ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter in DRG | 1.8 | ||||
| Avg LOS at DRG | 3.75 | ||||
| Avg LOS with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 9.13 | ||||
| Readmission Rate at DRG | 22.9 | ||||
| Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 27.34 | ||||
| Unplanned Readmission Rate at DRG | 18.29 | ||||
| Unplanned Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 24.22 | ||||
| Total Medicare payments at DRG | $1,641,467,496 | ||||
| Total Medicare payments with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $1,817,057 | ||||
| Total Medicare payment per Day at DRG | $1,526 | ||||
| Total Medicare payment per Day with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $1,422 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,730 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $12,979 | ||||
| Total Medicare Charges at DRG | $8,050,963,680 | ||||
| Total Medicare Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $6,681,250 | ||||
| Avg Charges at DRG | $28,105 | ||||
| Avg Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $47,723 | ||||
| Mortality Rate at DRG | 0.24 | ||||
| Mortality Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 10.84 | ||||
| SNF Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 12.86 | ||||
| Home Discharge Rate at DRG | 59.73 | ||||
| Home Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 31.43 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 559: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 052: SPINAL DISORDERS AND INJURIES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 65,966 | ||||
| Total Hospitalizations with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 99 | ||||
| DRG Share of Total Hospitalizations | 0.2 | ||||
| % of Total ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter in DRG | 1.27 | ||||
| Avg LOS at DRG | 13.11 | ||||
| Avg LOS with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 14.42 | ||||
| Readmission Rate at DRG | 21.08 | ||||
| Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 15.85 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | NA | ||||
| Total Medicare payments at DRG | $1,323,430,782 | ||||
| Total Medicare payments with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $2,083,234 | ||||
| Total Medicare payment per Day at DRG | $1,530 | ||||
| Total Medicare payment per Day with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $1,459 | ||||
| Total Medicare payment per Hospitalization at DRG | $20,062 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $21,043 | ||||
| Total Medicare Charges at DRG | $3,810,466,828 | ||||
| Total Medicare Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $7,254,494 | ||||
| Avg Charges at DRG | $57,764 | ||||
| Avg Charges with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | $73,278 | ||||
| Mortality Rate at DRG | 1.49 | ||||
| Mortality Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 24.48 | ||||
| SNF Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 17.17 | ||||
| Home Discharge Rate at DRG | 12.66 | ||||
| Home Discharge Rate with ICD T380X5D - Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 16.16 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| COMMUNITY HOSPITAL | 901 MACARTHUR BLVD | MUNSTER | IN | 46321 | 313 |
| MOUNTAINVIEW HOSPITAL | 3100 N TENAYA WAY | LAS VEGAS | NV | 89128 | 169 |
| ASCENSION MACOMB - OAKLAND HOSPITAL | 11800 E 12 MILE RD | WARREN | MI | 48093 | 115 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. FARZIN FARHANG | 2036 GLENVIEW DR | LAS VEGAS | NV | 89134 | 80 |
| Dr. KARYN RAE DODDY | 1701 BEARDEN DR | LAS VEGAS | NV | 89106 | 72 |
| Dr. MARK HENRY STEINHAUER | 10301 GATEWAY BLVD W | EL PASO | TX | 79925 | 33 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. PADMAJA KONDAMURI | 8840 CALUMET AVE | MUNSTER | IN | 46321 | 282 |
| Dr. DANIEL MARTIN RYAN | 13850 E 12 MILE RD | WARREN | MI | 48088 | 113 |
| Dr. ANDREA PERNELL | 2810 W CHARLESTON BLVD | LAS VEGAS | NV | 89102 | 109 |